ACAD
30.3
-1.13
-3.60%
AEMD
5.88
-0.13
-2.16%
APRI
0.367
-0.033
-8.250%
ARNA
1.65
-0.16
-8.84%
ATEC
0.301
+0.021
+7.500%
CNAT
2
-0.04
-1.96%
CRXM
0.16
-0.015
-8.6015%
CYTX
2
-0.02
-0.99%
DXCM
75.91
-1.55
-2.00%
GNMK
8.14
-0.21
-2.51%
HALO
7.78
-0.66
-7.82%
ILMN
135.48
-3.43
-2.47%
INNV
0.215
-0.015
-6.522%
INO
8.29
-0.88
-9.60%
ISCO
1.91
-0.14
-6.83%
ISIS
57.56
0.00
0.00%
LGND
113.12
+1.33
+1.19%
LPTN
2.05
-0.13
-5.96%
MBVX
0.55
0.00
-0.45%
MEIP
1.27
-0.09
-6.62%
MNOV
6.96
-0.04
-0.57%
MRTX
5.55
-0.43
-7.19%
MSTX
0.464
+0.014
+3.203%
NBIX
41.79
-1.49
-3.44%
NUVA
57.79
-0.14
-0.24%
ONCS
1.59
-0.04
-2.45%
ONVO
3.1
-0.25
-7.46%
OREX
0.41
-0.039
-8.5784%
OTIC
14.93
-0.65
-4.17%
QDEL
16.67
-0.42
-2.46%
RCPT
231.96
0.00
0.00%
RGLS
5.01
-0.28
-5.29%
RMD
59.22
-1.3
-2.15%
SCIE
0.004
-0.001
-13.7255%
SPHS
1.72
-0.14
-7.53%
SRNE
5.49
-0.13
-2.31%
TROV
4.36
-0.19
-4.18%
VICL
4.22
-0.25
-5.59%
VOLC
18
0.00
0.00%
ZGNX
7.35
-0.74
-9.15%
ACAD
30.3
-1.13
-3.60%
AEMD
5.88
-0.13
-2.16%
APRI
0.367
-0.033
-8.250%
ARNA
1.65
-0.16
-8.84%
ATEC
0.301
+0.021
+7.500%
CNAT
2
-0.04
-1.96%
CRXM
0.16
-0.015
-8.6015%
CYTX
2
-0.02
-0.99%
DXCM
75.91
-1.55
-2.00%
GNMK
8.14
-0.21
-2.51%
HALO
7.78
-0.66
-7.82%
ILMN
135.48
-3.43
-2.47%
INNV
0.215
-0.015
-6.522%
INO
8.29
-0.88
-9.60%
ISCO
1.91
-0.14
-6.83%
ISIS
57.56
0.00
0.00%
LGND
113.12
+1.33
+1.19%
LPTN
2.05
-0.13
-5.96%
MBVX
0.55
0.00
-0.45%
MEIP
1.27
-0.09
-6.62%
MNOV
6.96
-0.04
-0.57%
MRTX
5.55
-0.43
-7.19%
MSTX
0.464
+0.014
+3.203%
NBIX
41.79
-1.49
-3.44%
NUVA
57.79
-0.14
-0.24%
ONCS
1.59
-0.04
-2.45%
ONVO
3.1
-0.25
-7.46%
OREX
0.41
-0.039
-8.5784%
OTIC
14.93
-0.65
-4.17%
QDEL
16.67
-0.42
-2.46%
RCPT
231.96
0.00
0.00%
RGLS
5.01
-0.28
-5.29%
RMD
59.22
-1.3
-2.15%
SCIE
0.004
-0.001
-13.7255%
SPHS
1.72
-0.14
-7.53%
SRNE
5.49
-0.13
-2.31%
TROV
4.36
-0.19
-4.18%
VICL
4.22
-0.25
-5.59%
VOLC
18
0.00
0.00%
ZGNX
7.35
-0.74
-9.15%
Home » Archive by Category

Drug Discovery

San Diego’s Antibody-Drug Conjugate Research Highlighted at #WorldADC Meeting in October

November 24, 2014 – 8:11 am
WorldADC

San Diego was host to the World Antibody Drug Conjugate (ADC) Meeting and Awards October 26-29th 2014. ADCs are an exciting new class of oncology therapeutics utilizing monoclonal antibodies conjugated to cytotoxic drugs, resulting in …

SDBN August 21st 2012 Event At The Sanford Consortium For Regenerative Medicine

August 3, 2012 – 12:41 pm

The Sanford Consortium for Regenerative Medicine is a stem cell research facility representing a collaboration between five of San Diego’s finest research institutions: Sanford-Burnham Medical Research Institute, The Salk Institute, The Scripps Research Institute and …

SDBN June 25th Event With Lilly: Open Innovation Drug Discovery

June 4, 2012 – 1:48 am

San Diego biotech has grown thanks to a collaborative spirit which is sometimes manifested in the acquisition and joining of companies towards a common goal. Lilly’s presence here is indicative of this type of growth, …

San Diego’s Biotechnology Companies: Who’s Taking Off?

March 8, 2012 – 9:13 am

Here at SDBN we’ve been updating our directory of 400+ San Diego biotech companies.  We were surprised to find close to 40 companies removed from the local scene – due to acquisition or shut down.  …

SDBN March 26th 2012 Event with Organovo

March 6, 2012 – 1:59 pm

Organovo is an exciting San Diego biotech company with technology to create human tissue through a technique called 3D bioprinting. The tissue can be used for drug discovery and development, and the company has been …

Focus on San Diego: Life Science Conferences Spring 2012

January 31, 2012 – 11:56 am

This spring San Diego downtown will be buzzing with scientific discussions as our city hosts a number of major scientific symposia.  We are excited to attend and soak in all the science that will be …

Virtual Biotech Part 1: What We Learned About Effectively Outsourcing a Drug Discovery Program

July 28, 2011 – 12:04 pm

The first in our Virtual Biotech series, our July 19th event was a success.  Thanks to our participants – some of San Diego’s leading virtual drug discovery scientists and CROs – for sharing their valuable …

SDBN July 19th Event: Virtual Biotech Part 1: How to Effectively Outsource a Drug Discovery Program

July 1, 2011 – 3:47 pm

Changes in the drug discovery landscape have presented many tough challenges for our region, including downsizing for larger companies and a dearth of VC funding for startups. With these challenges come opportunities, however, because drug …

SDBN June 21st Event Featuring aTyr Pharma

May 27, 2011 – 9:58 am

The San Diego Biotechnology Network’s June 21st event will feature aTyr Pharma, with Board Member and CEO Jeffry Watkins (Bio) giving a talk titled “Innovation: Where is our Biology?” aTyr is developing therapeutics based on …

SDBN April 19th 2011 Event Featuring Celgene

March 22, 2011 – 6:15 pm

Through research, acquisitions, and mergers, Celgene has built a robust product portfolio and pipeline in hematology and oncology. This accomplishment is quite a feat in today’s environment, with pharma pipelines dwindling, and they are one …